NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is P73398102. A total of 49 filers reported holding NYMOX PHARMACEUTICAL CORP in Q1 2020. The put-call ratio across all filers is 1.12 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,000 | -66.7% | 2,500 | 0.0% | 0.00% | -100.0% |
| Q1 2022 | $3,000 | 0.0% | 2,500 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $3,000 | -40.0% | 2,500 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $5,000 | +25.0% | 2,500 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $4,000 | -33.3% | 2,500 | 0.0% | 0.00% | -50.0% |
| Q1 2021 | $6,000 | 0.0% | 2,500 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $6,000 | 0.0% | 2,500 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $6,000 | -25.0% | 2,500 | 0.0% | 0.00% | -33.3% |
| Q2 2020 | $8,000 | +60.0% | 2,500 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $5,000 | 0.0% | 2,500 | 0.0% | 0.00% | +50.0% |
| Q4 2019 | $5,000 | 0.0% | 2,500 | 0.0% | 0.00% | -33.3% |
| Q3 2019 | $5,000 | +25.0% | 2,500 | 0.0% | 0.00% | +50.0% |
| Q2 2019 | $4,000 | -20.0% | 2,500 | 0.0% | 0.00% | -33.3% |
| Q1 2019 | $5,000 | +66.7% | 2,500 | 0.0% | 0.00% | +50.0% |
| Q4 2018 | $3,000 | -50.0% | 2,500 | 0.0% | 0.00% | -33.3% |
| Q3 2018 | $6,000 | -25.0% | 2,500 | 0.0% | 0.00% | -40.0% |
| Q2 2018 | $8,000 | -27.3% | 2,500 | 0.0% | 0.01% | -28.6% |
| Q1 2018 | $11,000 | – | 2,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First Citizens Financial Corp | 35,100 | $82,000 | 0.11% |
| Patriot Financial Group Insurance Agency, LLC | 71,060 | $166,000 | 0.08% |
| Willow Creek Wealth Management Inc. | 24,224 | $57,000 | 0.03% |
| WEBSTER BANK, N. A. | 60,000 | $140,000 | 0.02% |
| HighPoint Advisor Group LLC | 34,000 | $98,000 | 0.02% |
| Brown Advisory Securities, LLC | 28,000 | $60,000 | 0.02% |
| WMS Partners, LLC | 18,000 | $42,000 | 0.01% |
| WEDBUSH SECURITIES INC | 33,900 | $79,000 | 0.01% |
| ExodusPoint Capital Management, LP | 56,618 | $132,000 | 0.01% |
| Qube Research & Technologies Ltd | 66,800 | $156,000 | 0.01% |